"Dedicated to conducting clinical studies, Synexus have been investigating the effectiveness of new medicines and treatments for more than 25 years."

During the past decade, Synexus - Manchester Clinical Research Centre conducted 14 clinical trials. In the 10-year time frame, 14 clinical trials started and 14 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 9 clinical trials were completed. i.e. 128.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Synexus - Manchester Clinical Research Centre" #1 sponsor was "Eli Lilly and Company" with 4 trials, followed by "Pfizer" with 4 trials sponsored, "Kowa Research Europe" with 2 trials sponsored, "Phathom Pharmaceuticals, Inc." with 2 trials sponsored and "Allergan" with 2 trials sponsored. Other sponsors include 3 different institutions and companies that sponsored additional 13 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Synexus - Manchester Clinical Research Centre" #1 collaborator was "Brigham and Women's Hospital" with 1 trials as a collaborator and "CoLucid Pharmaceuticals" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Synexus - Manchester Clinical Research Centre" are "Dyslipidemia" (3 trials), "Cardiovascular Disease" (2 trials), "Hyperlipidemia" (2 trials), "Migraine" (2 trials) and "Psoriasis" (2 trials). Many other conditions were trialed in "Synexus - Manchester Clinical Research Centre" in a lesser frequency.

Most popular intervention types in "Synexus - Manchester Clinical Research Centre" are "Drug" (19 trials), "Other" (3 trials), "Biological" (1 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (13 trials), "Atorvastatin" (2 trials), "Bococizumab (PF-04950615; RN316)" (2 trials), "Lansoprazole" (2 trials) and "Lasmiditan" (2 trials). Other intervention names were less common.

The vast majority of trials in "Synexus - Manchester Clinical Research Centre" are 20 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Synexus - Manchester Clinical Research Centre". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 14 completed trials in Synexus - Manchester Clinical Research Centre, undefined suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in Synexus - Manchester Clinical Research Centre, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 18 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".